Etsuro Nanishi

Bell's palsy and SARS-CoV-2 vaccines

Al Ozonoff, Etsuro Nanishi, Ofer Levy · The Lancet Infectious Diseases · 2021 · 160 citations · Full text

Vaccination, Vaccine Development, Sars-cov-2 Vaccines +4

An adjuvant strategy enabled by modulation of the physical properties of microbial ligands expands antigen immunogenicity

Francesco Borriello, Valentina Poli, Ellen Shrock et al. · Cell · 2022 · 116 citations · Full text

Vaccination, Mucosal Vaccination, Microbial Pathogens +11

An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice

Etsuro Nanishi, Francesco Borriello, Timothy R. O’Meara et al. · Science Translational Medicine · 2022 · 107 citations

Vaccination, Global Deployment, Vaccine Development +12

An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice.

Etsuro Nanishi, Francesco Borriello, Timothy R. O’Meara et al. · PubMed · 2022 · 69 citations · Full text

The utility of biomarkers in differentiating bacterial from non-bacterial lower respiratory tract infection in hospitalized children: Difference of the diagnostic performance between acute pneumonia and bronchitis

Takayuki Hoshina, Etsuro Nanishi, Shunsuke Kanno et al. · Journal of Infection and Chemotherapy · 2014 · 54 citations

Respiratory Diseases, Pediatrics, Respiratory Infection +8